date,title,source
Nov-05-18,Iterum Therapeutics plc to Participate in Investor Conferences in November and December,GlobeNewswire
Nov-14-18,Iterum Reports Third Quarter 2018 Financial Results and Recent Highlights,GlobeNewswire
Dec-20-18,Are Insiders Buying Iterum Therapeutics plc (NASDAQ:ITRM) Stock?,Simply Wall St.
Jan-17-19,Antimicrobials Working Group Announces Updates to Leadership Team,PR Newswire
Feb-19-19,Iterum to Present at the 8th Annual SVB Leerink Partners Global Healthcare Conference,GlobeNewswire
Feb-21-19,What Kind Of Shareholders Own Iterum Therapeutics plc (NASDAQ:ITRM)?,Simply Wall St.
Mar-19-19,Iterum Therapeutics Receives QIDP for Oral and IV Sulopenem in Four Additional Indications as well as Fast Track Designation,GlobeNewswire
Mar-25-19,Iterum Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results,GlobeNewswire
Mar-28-19,Iterum Therapeutics PLC (ITRM) Moves to Buy: Rationale Behind the Upgrade,Zacks
Mar-28-19,Will Iterum Therapeutics Continue to Surge Higher?,Zacks
Apr-11-19,Iterum Therapeutics Presents Data on Risks for Treatment Failure Associated with Uncomplicated Urinary Tract Infection and Activity of its Novel Antibiotic Sulopenem at ECCMID 2019,GlobeNewswire
Apr-12-19,Antimicrobials Working Group Highlights Member Company Participation at the 29th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID),PR Newswire
May-14-19,Iterum Therapeutics Reports First Quarter 2019 Financial Results,GlobeNewswire
